By Julie A. Vetalice
Subchondral Solutions received FDA 510(k) clearance to market the fenestrated, cannulated S4 Screw System™ to treat osteochondral fractures. S4 is the company's first FDA-cleared device in its platform that will address joint pain and damage with biomechanical and bioactive implants. The approach focuses on early biomechanical support for the entire bone/cartilage unit. Subchondral Solutions was established in California in 2014. Source: Subchondral Solutions, Inc. Read the full article at Orthoworld.com
0 Comments
Leave a Reply. |
ArchivesCategories |